Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

EXICURE, INC. (XCUR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

EXICURE, INC. (XCUR), most recent 12 months reported: revenue $0, net loss $8.28M, free cash flow -$8.56M. From SEC filings. Others in Pharmaceutical Preparations: Vera Therapeutics, Inc. · VERU INC. · Viking Therapeutics, Inc. · WHITEHAWK THERAPEUTICS, INC. · XBiotech Inc. · XENON PHARMACEUTICALS INC. · Zentalis Pharmaceuticals, Inc. · ZYVERSA THERAPEUTICS, INC.

Stock screener

Watchlist